Essa, Hani, Walker, Lauren 
ORCID: 0000-0002-3827-4387, Mohee, Kevin, Oguguo, Chukwuemeka, Douglas, Homeyra, Kahn, Matthew, Rao, Archana, Bellieu, Julie, Hadcroft, Justine, Hartshorne-Evans, Nick et al (show 5 more authors)
(2022)
Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospitalisation and clinic attendance.
OPEN HEART, 9 (2).
e001979-.
|
PDF
Multispecialty multidisciplinary input into comorbidities along with treatment optimisation in heart failure reduces hospita.pdf - Published version Download (950kB) | Preview |
Abstract
<h4>Aims</h4>Heart failure (HF) is associated with comorbidities which independently influence treatment response and outcomes. This retrospective observational study (January 2020-June 2021) analysed the impact of monthly HF multispecialty multidisciplinary team (MDT) meetings to address management of HF comorbidities and thereby on provision, cost of care and HF outcomes.<h4>Methods</h4>Patients acted as their own controls, with outcomes compared for equal periods (for each patient) pre (HF MDT) versus post-MDT (multispecialty) meeting. The multispecialty MDT comprised HF cardiologists (primary, secondary, tertiary care), HF nurses, nephrologist, endocrinologist, palliative care, chest physician, pharmacist, clinical pharmacologist and geriatrician. Outcome measures were (1) all-cause hospitalisations, (2) outpatient clinic attendances and (3) cost.<h4>Results</h4>334 patients (mean age 72.5±11 years) were discussed virtually through MDT meetings and follow-up duration was 13.9±4 months. Mean age-adjusted Charlson Comorbidity Index was 7.6±2.1 and Rockwood Frailty Score 5.5±1.6. Multispecialty interventions included optimising diabetes therapy (haemoglobin A1c-HbA1c pre-MDT 68±11 mmol/mol vs post-MDT 61±9 mmol/mol; p<0.001), deprescribing to reduce anticholinergic burden (pre-MDT 1.85±0.4 vs 1.5±0.3 post-MDT; p<0.001), initiation of renin-angiotensin aldosterone system inhibitors in HF with reduced ejection fraction (HFrEF) with advanced chronic kidney disease (9% pre vs 71% post-MDT; p<0.001). Other interventions included potassium binders, treatment of anaemia, falls assessment, management of chest conditions, day-case ascitic, pleural drains and palliative support. Total cost of funding monthly multispecialty meetings was £32 400 and resultant 64 clinic appointments cost £9600. The post-MDT study period was associated with reduction in 481 clinic appointments (cost saving £72150) and reduced all-cause hospitalisations (pre-MDT 1.1±0.4 vs 0.6±0.1 post-MDT; p<0.001), reduction of 1586 hospital bed-days and cost savings of £634 400. Total cost saving to the healthcare system was £664 550.<h4>Conclusion</h4>HF multispecialty virtual MDT model provides integrated, holistic care across all healthcare tiers for management of HF and associated comorbidities. This approach is associated with reduced clinic attendances and all-cause hospitalisations, leading to significant cost savings.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Humans, Stroke Volume, Hospitalization, Comorbidity, Aged, Aged, 80 and over, Middle Aged, Ambulatory Care Facilities, Heart Failure |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences Faculty of Health and Life Sciences > Clinical Directorate Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 26 Oct 2022 11:25 |
| Last Modified: | 18 Jan 2023 19:49 |
| DOI: | 10.1136/openhrt-2022-001979 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3165781 |
Dimensions
Dimensions
